Takeda receives $70m from Japan government for pandemic flu vaccine
Takeda has received a ¥7.2bn ($70m) subsidy from the Japanese government to expand production capacity of its cell-culture pandemic influenza vaccine.
Archives for April 29, 2014
GE to in-license Promosome mammalian cell lines
GE Healthcare Life Sciences has signed a licensing agreement for Promosome’s suite of mammalian cell line development technologies, which aim to increase protein expression in mammalian cell culture.
Lupin launches JV with Yoshindo to develop biosimilars for Japan
In an attempt to corner the Japanese biosimilar market, Pharma companies Lupin and Yoshindo are creating a new entity, known as YL Biologics (YLB).
Waters sees chromatography growth despite flat Q1
Bioprocessing instrument manufacturer Waters has reported a flat Q1, but management predicts new products and a delayed release of capital from large pharma will lead to growth in 2014.